Home

Haiku Beschwerden Kompliment spironolactone mechanism of action heart failure Klatsch Assimilieren Schuldner

Treatment of CHF - Pharmacology
Treatment of CHF - Pharmacology

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart |  VHRM
Spotlight on Spironolactone Oral Suspension for the Treatment of Heart | VHRM

Reappraisal on pharmacological and mechanical treatments of heart failure |  Cardiovascular Diabetology | Full Text
Reappraisal on pharmacological and mechanical treatments of heart failure | Cardiovascular Diabetology | Full Text

Hormones and Hemodynamics in Heart Failure | NEJM
Hormones and Hemodynamics in Heart Failure | NEJM

Pathophysiology of high potassium concentration in heart failure. |  Download Scientific Diagram
Pathophysiology of high potassium concentration in heart failure. | Download Scientific Diagram

Pharmaceuticals | Free Full-Text | COVID-19—The Potential Beneficial  Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection | HTML
Pharmaceuticals | Free Full-Text | COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection | HTML

Biomolecules | Free Full-Text | Spironolactone and XPB: An Old Drug with a  New Molecular Target | HTML
Biomolecules | Free Full-Text | Spironolactone and XPB: An Old Drug with a New Molecular Target | HTML

Diuretics Part 2
Diuretics Part 2

Mineralocorticoid receptor antagonists, a class beyond spironolactone —  Focus on the special pharmacologic properties of eplerenone - International  Journal of Cardiology
Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology

Potassium Sparing Diuretics - Pharmacological Actions, Pharmacokinetics,  Uses, Adverse Effects, Interactions | Pharmacology
Potassium Sparing Diuretics - Pharmacological Actions, Pharmacokinetics, Uses, Adverse Effects, Interactions | Pharmacology

Combined aquaretic and diuretic therapy in acute heart failure | IJNRD
Combined aquaretic and diuretic therapy in acute heart failure | IJNRD

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome  in Myocardial Infarction Patients With Heart Failure | Journal of the  American Heart Association
Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure | Journal of the American Heart Association

Aldosterone antagonists
Aldosterone antagonists

Proposed Treatment Algorithm for the Use of Spironolactone in Heart... |  Download Scientific Diagram
Proposed Treatment Algorithm for the Use of Spironolactone in Heart... | Download Scientific Diagram

Association of Active and Passive Components of LV Diastolic Filling With  Exercise Intolerance in Heart Failure With Preserved Ejection Fraction:  Mechanistic Insights From Spironolactone Response | JACC: Cardiovascular  Imaging
Association of Active and Passive Components of LV Diastolic Filling With Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Mechanistic Insights From Spironolactone Response | JACC: Cardiovascular Imaging

Interaction Between Spironolactone and Natriuretic Peptides in Patients  With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial -  ScienceDirect
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect

K-Sparing Diuretics - Renal - Medbullets Step 1
K-Sparing Diuretics - Renal - Medbullets Step 1

treatment_of_heart_failure [TUSOM | Pharmwiki]
treatment_of_heart_failure [TUSOM | Pharmwiki]

Aldactone Mechanism of Action | MIMS Philippines
Aldactone Mechanism of Action | MIMS Philippines

Beyond Furosemide: The Role of Diuretics in Congestive Heart Failure Part 2  - Spironolactone | Today's Veterinary Practice
Beyond Furosemide: The Role of Diuretics in Congestive Heart Failure Part 2 - Spironolactone | Today's Veterinary Practice

Pharmacotherapy of Heart Failure | Basicmedical Key
Pharmacotherapy of Heart Failure | Basicmedical Key

Effects of mineralocorticoid receptor antagonist spironolactone on atrial  conduction and remodeling in patients with heart failure - Journal of  Cardiology
Effects of mineralocorticoid receptor antagonist spironolactone on atrial conduction and remodeling in patients with heart failure - Journal of Cardiology

Interaction Between Spironolactone and Natriuretic Peptides in Patients  With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial -  ScienceDirect
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect

Endocrine and haemodynamic changes in resistant hypertension, and blood  pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms  substudies - The Lancet Diabetes & Endocrinology
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies - The Lancet Diabetes & Endocrinology

Spironolactone – Mechanism, side effects, interactions and precautions
Spironolactone – Mechanism, side effects, interactions and precautions